BioVie clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
A Phase 3 Study of NE3107 in Probable Alzheimer's DiseaseNCT04669028NE3107Completed2023-09-30Actual

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline in performance on the Cogstate Cognition battery*. After: Measure: Change from Baseline in performance on the Cogstate Cognition battery* Measure: Change from Baseline in PROMIS Cognitive Function Short Form 8a (SF-8a) Measure: Change from Baseline in PROMIS Fatigue Short Form 13a (SF-13a) Measure: Change from Baseline in PROMIS Sleep Disturbance Short Form 8a (SF-8a) Measure: Change from Baseline in SF-12 Health Survey (Physical Component Scores) Measure: Change from Baseline in SF-12 Health Survey (Mental Component Scores) Measure: Change from Baseline in DePaul Symptom Questionnaire (DSQ) Post-Exertional Malaise Measure: Composite Benefit Score.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2026. After: 6 Aug 2026.

Check registry source
A Study of NE3107 in Early Parkinson's

NCT06757010 · BioVie Inc.

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from baseline in the MDS-UPDRS Part III. After: Measure: Monocyte Lymphocyte Ratio (MLR).

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 57 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline in performance on the Cogstate Cognition battery. After: Measure: Change from Baseline in performance on the Cogstate Cognition battery*.

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 208 participants (planned). After: 203 participants (actual).

Primary completion date changed

Before: Jun 2026. After: Aug 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source
A Study of NE3107 in Early Parkinson's

NCT06757010 · BioVie Inc.

· 2 fields changed

Primary completion date changed

Before: 1 Dec 2025. After: 1 May 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in performance on the Cogstate Cognition battery. After: Measure: Change from Baseline in performance on the Cogstate Cognition battery.

Check registry source